Your browser doesn't support javascript.
loading
A Case of Acute Myeloid Leukemia after Adalimumab Treatment in Psoriatic Arthritis
Hong-Ki MIN; Jae-Ho LEE; Hae-Min LEE; Eunsil KOH; Ju-Yeon HEO; Jun-Ki MIN; Sung-Hwan PARK.
Journal of Rheumatic Diseases ; : 91-94, 2012.
Article in English | WPRIM | ID: wpr-15488
ABSTRACT
Hematologic malignancies and lymphoproliferative disorders have been reported after using tumor necrosis factor-alpha inhibitor in patients suffering from spondyloarthropathy. Previously reported cases were treated by using infliximab and etanercept. Usually, it takes approximately several months for leukemia or lymphoproliferative disorders to occur after the application of those agents. However, we report a case of acute myeloid leukemia that developed after short term usage of adalimumab in a patient suffering from psoriatic arthritis.
Subject(s)

Fulltext
Print
XML
Search on Google
Full text: Available Index: WPRIM (Western Pacific) Main subject: Stress, Psychological / Immunoglobulin G / Leukemia, Myeloid, Acute / Leukemia / Arthritis, Psoriatic / Tumor Necrosis Factor-alpha / Receptors, Tumor Necrosis Factor / Hematologic Neoplasms / Spondylarthropathies / Antibodies, Monoclonal, Humanized Limits: Humans Language: English Journal: Journal of Rheumatic Diseases Year: 2012 Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
Search on Google
Full text: Available Index: WPRIM (Western Pacific) Main subject: Stress, Psychological / Immunoglobulin G / Leukemia, Myeloid, Acute / Leukemia / Arthritis, Psoriatic / Tumor Necrosis Factor-alpha / Receptors, Tumor Necrosis Factor / Hematologic Neoplasms / Spondylarthropathies / Antibodies, Monoclonal, Humanized Limits: Humans Language: English Journal: Journal of Rheumatic Diseases Year: 2012 Type: Article